Catalyst
Slingshot members are tracking this event:
US FDA Approves Two Supplemental Indications for Harvoni in Chronic Hepatitis C Patients With Advanced Liver Disease
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GILD |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 16, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Advanced Liver Disease, Sofosbuvir, Ledipasvir, Child-pugh A, Hcv Genotype 1-infected, Decompensated Cirrhosis, Hcv/hiv-1 Coinfection, 4 Liver Transplant Recipients, Genotype 1
